Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03535740
Brief Title: A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (ALTA-2)

First Submitted : May 9, 2018
First Submitted that Met QC Criteria : May 22, 2018
First Posted : May 24, 2018

Results First Submitted : September 24, 2021
Results First Submitted that Met QC Criteria : September 24, 2021
Results First Posted : October 25, 2021

Last Update Submitted that Met QC Criteria : December 15, 2021
Last Update Posted : January 5, 2022